Digital surveillance in post‐coronavirus China: A feminist view on the price we pay

por Yu, Ai
Publicado 2020

Accountability as mourning: Accounting for death in the time of COVID-19()

por Yu, Ai
Publicado 2021

Bioengineered miR-34a modulates mitochondrial inner membrane protein 17 like 2 (MPV17L2) expression toward the control of cancer cell mitochondrial functions

por Yi, Wan-Rong, Tu, Mei-Juan, Yu, Ai-Xi, Lin, Jun, Yu, Ai-Ming
Publicado 2022

Author correction to ‘Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis in vivo’...

por Deng, Linglong, Petrek, Hannah, Tu, Mei-Juan, Batra, Neelu, Yu, Ai-Xi, Yu, Ai-Ming
Publicado 2023

Bioengineered miR-124-3p prodrug selectively alters the proteome of human carcinoma cells to control multiple cellular components and lung metastasis in vivo

por Deng, Linglong, Petrek, Hannah, Tu, Mei-Juan, Batra, Neelu, Yu, Ai-Xi, Yu, Ai-Ming
Publicado 2021

MicroRNAs in non‐small cell lung cancer: Gene regulation, impact on cancer cellular processes, and therapeutic potential

por Petrek, Hannah, Yu, Ai‐Ming
Publicado 2019

MicroRNAs in the Regulation of Solute Carrier Proteins Behind Xenobiotic and Nutrient Transport in Cells

por Yi, Colleen, Yu, Ai-Ming
Publicado 2022

A Novel Integrated Pharmacokinetic-Pharmacodynamic Model to Evaluate Combination Therapy and Determine In Vivo Synergism

por Choi, Young Hee, Zhang, Chao, Liu, Zhenzhen, Tu, Mei-Juan, Yu, Ai-Xi, Yu, Ai-Ming
Publicado 2021

Genetically engineered pre-microRNA-34a prodrug suppresses orthotopic osteosarcoma xenograft tumor growth via the induction of apoptosis and cell cycle arrest

por Zhao, Yong, Tu, Mei-Juan, Wang, Wei-Peng, Qiu, Jing-Xin, Yu, Ai-Xi, Yu, Ai-Ming
Publicado 2016

Bioengineered miR-328-3p modulates GLUT1-mediated glucose uptake and metabolism to exert synergistic antiproliferative effects with chemotherapeutics

por Yi, Wanrong, Tu, Mei-Juan, Liu, Zhenzhen, Zhang, Chao, Batra, Neelu, Yu, Ai-Xi, Yu, Ai-Ming
Publicado 2020

Recombinant Technologies Facilitate Drug Metabolism, Pharmacokinetics, and General Biomedical Research

por Cronin, Joseph M., Yu, Ai-Ming
Publicado 2023

Advanced knowledge in drug metabolism and pharmacokinetics

por Yu, Ai-Ming, Zhong, Xiao-bo
Publicado 2016

Deliver the promise: RNAs as a new class of molecular entities for therapy and vaccination

por Yu, Ai-Ming, Tu, Mei-Juan
Publicado 2022

RNAi-Based Therapeutics and Novel RNA Bioengineering Technologies

por Traber, Gavin M., Yu, Ai-Ming
Publicado 2023

Regenerative peripheral nerve interface prevents neuroma formation after peripheral nerve transection

por Wang, Zheng, Yi, Xin-Zeyu, Yu, Ai-Xi
Publicado 2022

RNA Drugs and RNA Targets for Small Molecules: Principles, Progress, and Challenges

por Yu, Ai-Ming, Choi, Young Hee, Tu, Mei-Juan
Publicado 2020

Editorial: Post-transcriptional regulation and its misregulation: From molecular basis to translational medicine

por Tian, Ye, Yu, Ai-Ming, Yin, Chong, Qian, Airong
Publicado 2022

Diagnostic value of methylated branched chain amino acid transaminase 1/IKAROS family zinc finger 1 for colorectal cancer

por Xu, Ke, Yu, Ai-Ru, Pan, Shen-Bin, He, Jie
Publicado 2023

SUMOhydro: A Novel Method for the Prediction of Sumoylation Sites Based on Hydrophobic Properties

por Chen, Yong-Zi, Chen, Zhen, Gong, Yu-Ai, Ying, Guoguang
Publicado 2012

A Pilot Study on the Satisfaction of Long-Term Care Services in Taiwan

por Lee, Amy H. I., Kang, He-Yau, Liu, Yu-Ai
Publicado 2021